CALLUNA PHARMA AS
932255189ActiveClinical stage biotech pioneering antibodies for inflammation and fibrosis.
Oversigt
- 10
- Medarbejdere
- 26.9mio NOK
- Omsætning
- 2023
- Grundlagt
Nøglebeslutningstagere
Susanne Stuffers MD PhD
Board member
Caroline Kurtz
Chief Scientific Officer
Gijs van den Brink MD PhD
Board member
Vincent Loon
Observer to the Board
+15 flere kontakter i Funnelfeedr
Beskrivelse
Calluna Pharma is a global biotechnology company specializing in developing therapeutics focused on inflammation and fibrosis. Driven by a lean, committed team, the company is currently in the clinical stage of development. Their innovative approach targets upstream disease amplifiers using first-in...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Aksjeselskap
- Momsnummer
- Ukendt
Beslutningstagere
19 kontakter i FunnelfeedrSusanne Stuffers MD PhD
Board member
Caroline Kurtz
Chief Scientific Officer
Gijs van den Brink MD PhD
Board member
Vincent Loon
Observer to the Board
Farzad Abdi-Dezfuli PhD
Board member
Mark Gaffney
Chief Executive Officer and member of the Board
Mark Altmeyer
Chair person
Marco Boorsma
Board member
Jonas Hallén
Chief Medical Officer
Jonas Hallén MD PhD
Chief Medical Officer
Margrethe Sørgaard
SVP Clinical Operations and Pharmacovigilance
Berte Poulsson
SVP Operations
Farzad Abdi-Dezfuli
Board member
Anjeza Gjino
Chief Financial Officer
Susanne Stuffers
Board member
Gijs van den Brink
Board member
Marco Boorsma PhD
Board member
Birgitte Gangmark Villmo
Observer to the Board
Andre kontakter
Benjamin Dyhre
Author
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
ScandiBio Therapeutics AB
0 medarbejdereAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Cereno Scientific AB
10–19 medarbejderePioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
Vicore Pharma Holding AB
5–9 medarbejdereDeveloping novel ATRAG drugs for severe respiratory diseases.
CANTARGIA AB
20–49 medarbejdereDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
Vicore Pharma AB
5–9 medarbejdereInnovative clinical-stage pharma developing severe lung disease treatments.
Udforsk mere
Spørgsmål om CALLUNA PHARMA AS
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo